Silab's Senevisium received the 1st prize of the C&T Allē Awards in the Actives/Anti-aging category at the Red Carpet Awards Gala on March 6, 2024 in Los Angeles, in parallel to the Beauty Accelerate conference.
The ingredient previously received in the 1st prize of the ICIC Award and the 1st prize of the Ringer Award.
According to Brigitte Closs-Gonthier, CEO and general manager of R&D, quality and communication at Silab, “We are very pleased that the high scientific level of this active ingredient has been recognized by the cosmetics industry. Senevisium in fact is an innovative cosmetic solution, the result of a cutting-edge research program that for the first time has demonstrated the consequences of the immunoevasion by senescent fibroblasts in the course of skin aging.”
The technology is a natural, anti-aging active ingredient obtained from Ginkgo biloba, with properties for reactivating the natural elimination of senescent fibroblasts by the immune system.
Senevisium also protects the skin from the effects of immunoevasive senescent fibroblasts on matrix synthesis and epidermal renewal.
Related: Silab Asserts Company Independence, Adapts Governance
In vitro and in vivo modeling studies by the company revealed the accentuation of the immunoevasion mechanism at the level of the skin after the age of 60, inducing profound changes (wrinkles, dull complexion, loss of elasticity and senescence spots).
Tested at 2% in white volunteers, it was unanimous that Senevisium made their skin firmer and their complexion lighter and more uniform after 28 days of treatment.
